Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms.

[1]  A. Rosenwald,et al.  Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV , 2022, Blood advances.

[2]  A. Rosenwald,et al.  Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage , 2021, Blood advances.

[3]  A. Rosenwald,et al.  Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma , 2021, Nature Communications.

[4]  K. Nakayama,et al.  Chromatin Protein PC4 Orchestrates B Cell Differentiation by Collaborating with IKAROS and IRF4. , 2020, Cell reports.

[5]  M. Ghielmini,et al.  Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  C. Copie-Bergman,et al.  Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease. , 2020, Blood advances.

[7]  Matthew A. Wyczalkowski,et al.  Discovery of driver non-coding splice-site-creating mutations in cancer , 2020, Nature Communications.

[8]  V. Seshan,et al.  Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups , 2020, Blood Cancer Journal.

[9]  A. Rosenwald,et al.  Localized and Advanced Stage Follicular Lymphomas Differ in their Gene Expression Profiles. , 2019, Blood.

[10]  R. Gascoyne,et al.  Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab , 2019, Journal of Immunotherapy for Cancer.

[11]  J. Cerhan,et al.  2016 US lymphoid malignancy statistics by World Health Organization subtypes , 2016, CA: a cancer journal for clinicians.

[12]  Y. Wu,et al.  Low natural killer (NK) cell counts in peripheral blood adversely affect clinical outcome of patients with follicular lymphoma , 2016, Blood Cancer Journal.

[13]  R. Gascoyne,et al.  Cell of origin of transformed follicular lymphoma. , 2015, Blood.

[14]  R. Siebert,et al.  Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma , 2014, Leukemia.

[15]  Michael Unterhalt,et al.  The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease. , 2012, Human pathology.

[16]  Ash A. Alizadeh,et al.  Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. , 2012, Blood.

[17]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[18]  P. Deloukas,et al.  Signatures of mutation and selection in the cancer genome , 2010, Nature.

[19]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[20]  Carolyn J. Brown,et al.  Prognostic significance of secondary cytogenetic alterations in follicular lymphomas , 2008, Genes, chromosomes & cancer.

[21]  R. Spang,et al.  Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma , 2008, Haematologica.

[22]  E. Lander,et al.  Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.

[23]  L. Staudt,et al.  Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. , 2007, Blood.

[24]  P. Leibson,et al.  Differential Regulation of Human NK Cell-Mediated Cytotoxicity by the Tyrosine Kinase Itk1 , 2007, The Journal of Immunology.

[25]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[26]  J. Zack,et al.  CD4 Expression on Activated NK Cells: Ligation of CD4 Induces Cytokine Expression and Cell Migration1 , 2006, The Journal of Immunology.

[27]  R. Gascoyne,et al.  Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes , 2003, British journal of haematology.

[28]  Gouri Nanjangud,et al.  Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas , 2001, Nature.

[29]  A. Rosenwald,et al.  Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus , 2016, Leukemia.

[30]  Christian Steidl,et al.  Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances. , 2009, Blood.

[31]  Peter Parham,et al.  KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. , 2002, Annual review of immunology.